Cargando…
Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer
BACKGROUND: The prognostic value of postoperative (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) to patients with gastric cancer remains unclear. This study aims to investigate the prognostic value of whole body (WB) metabolic tumor burden (MTB(WB)) on...
Autores principales: | Sun, Gaofeng, Cheng, Chao, Li, Xiao, Wang, Tao, Yang, Jian, Li, Danni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431021/ https://www.ncbi.nlm.nih.gov/pubmed/30902116 http://dx.doi.org/10.1186/s40644-019-0205-9 |
Ejemplares similares
-
(18)F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer
por: Brito, Ana E., et al.
Publicado: (2017) -
PET Index of Bone Glucose Metabolism (PIBGM) Classification of PET/CT Data for Fever of Unknown Origin Diagnosis
por: Yang, Jian, et al.
Publicado: (2015) -
Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer
por: Liu, Yi, et al.
Publicado: (2019) -
Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from (18)F fluorodeoxyglucose PET/CT images in gastric cancer
por: Li, Junmeng, et al.
Publicado: (2022) -
Predictive value of baseline metabolic tumor burden on (18)F-FDG PET/CT for brain metastases in patients with locally advanced non-small-cell lung cancer
por: Shang, Jingjie, et al.
Publicado: (2022)